Dechra CEO: Osphos to produce sales of $10-15 million within three years
- 188
23 Feb 2015: Dechra Pharmaceuticals says profit rose over 11% in the past six months and CEO Ian Page says it can continue to grow at that level. He says most of that growth will be organic but it is also looking for bolt-on acquisitions.
IG Markets
Welcome to the official IG UK YouTube channel. Here you will find everything you need to become a successful trader. Learn more about IG's products, the economy, financial markets, and company insights.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit
Learn more about IG: https://upl.inc/the-world-of-ig
